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Abstract
Background:  Online Mendelian Inheritance in Man (OMIM) is a computerized database of
information about genes and heritable traits in human populations, based on information reported
in the scientific literature. Our objective was to establish an automated text-mining system for
OMIM that will identify genetically-related cancers and cancer-related genes. We developed the
computer program CGMIM to search for entries in OMIM that are related to one or more cancer
types. We performed manual searches of OMIM to verify the program results.
Results: In the OMIM database on September 30, 2004, CGMIM identified 1943 genes related to
cancer. BRCA2 (OMIM *164757), BRAF (OMIM *164757) and CDKN2A (OMIM *600160) were
each related to 14 types of cancer. There were 45 genes related to cancer of the esophagus, 121
genes related to cancer of the stomach, and 21 genes related to both. Analysis of CGMIM results
indicate that fewer than three gene entries in OMIM should mention both, and the more than
seven-fold discrepancy suggests cancers of the esophagus and stomach are more genetically related
than current literature suggests.
Conclusion: CGMIM identifies genetically-related cancers and cancer-related genes. In several
ways, cancers with shared genetic etiology are anticipated to lead to further etiologic hypotheses
and advances regarding environmental agents. CGMIM results are posted monthly and the source
code can be obtained free of charge from the BC Cancer Research Centre website http://
www.bccrc.ca/ccr/CGMIM.
Background
Cancers are complex diseases with multiple genetic and
environmental factors contributing to their development.
The most prominent success stories in cancer genetics to
date have involved genes that produce a recognizable pat-
tern of disease within certain rare families. Most cancers,
however, are sporadic and appear in people who do not
have a clear family history of the disease. These cancers are
currently being studied in epidemiological investigations
that examine genetics, environmental exposures or both.
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The studies often compare "cases" or affected individuals
to "controls" or unaffected individuals, to determine
which group has a higher frequency of a particular gene
variant or a greater level of exposure to an environmental
agent. The studies require logical hypotheses regarding the
genes to be tested and clear criteria for case definition.
Cases may be defined as people who have any of several
types of cancer, if those types are related. For example, epi-
demiologic studies of BRCA1 mutation carriers might
benefit from information collected about both breast and
ovarian cancer cases. But what genes are associated with a
group of cancers, and what cancers are associated with a
particular gene? The answers can be found in literature
regarding cancer genetics, microbiology, clinical medi-
cine, epidemiology and other sciences. More than 1% of
all human genes are associated with cancer [1] and infor-
mation about the association between genes and cancer
changes constantly.
Online Mendelian Inheritance in Man (OMIM; http://
www.ncbi.nlm.nih.gov/omim/) is a computerized data-
base of information about genes and heritable traits in
human populations. The database was created by Victor
McKusick at Johns Hopkins University and is now edited
by him and colleagues around the world.[2] We consider
it a particularly high-quality data source because it is
curated by a knowledgeable team, based on information
reported in the scientific literature, and continuously
updated. OMIM is maintained on the Internet by the
National Center for Biotechnology Information at the US
National Institutes of Health.[3] Data mining aims to dis-
cover unexpected trends and patterns from large sets of
data [4], and the rapid growth of biomedical literature
underscores the value of text-mining in particular. Text-
mining has been described as a modular process involving
document categorization, named entity tagging, fact and
information extraction, and collection-wide analysis.[5]
In document categorization, a subset of potentially rele-
vant documents is retrieved to increase the efficiency of
subsequent steps. Named entity tagging identifies the
important entities or objects mentioned in the article,
often using a list of synonyms. Fact and information
extraction identifies the relationships between entities.
Finally, in collection-wide analysis, information extracted
from different documents is integrated.
Many research studies aim to explore the association
between genes and cancer. The design of these studies
Table 1: The twenty pairs of cancer types with the highest ratio of observed (O) to expected (E) number of associated genes. The O/E 
ratio and a 95% confidence interval (95%CI) are provided. Results are based on cancers mentioned in Online Mendelian Inheritance in 
Man (OMIM; http://www.ncbi.nlm.nih.gov/omim/) searched September 30, 2004.
Pair of Cancer Types Number of Genes Related to Both O/E Ratio and 95%CI
Observed (O) Expected (E)
cervix – larynx 2 0.16 12.6 ± 4.9
larynx – mouth 2 0.17 11.6 ± 4.8
larynx – uterus 2 0.25 7.9 ± 3.9
esophagus – stomach 21 2.80 7.5 ± 1.2
larynx – stomach 3 0.44 6.9 ± 3.0
bladder – esophagus 10 1.51 6.6 ± 1.6
larynx – myeloma 1 0.15 6.6 ± 5.1
larynx – esophagus 1 0.16 6.2 ± 4.9
cervix – esophagus 6 1.02 5.9 ± 1.9
bladder – cervix 8 1.47 5.4 ± 1.6
cervix – uterus 8 1.59 5.1 ± 1.6
larynx – bladder 1 0.23 4.3 ± 4.1
pancreas – stomach 23 6.10 3.8 ± 0.8
cervix – stomach 10 2.74 3.7 ± 1.2
esophagus – mouth 4 1.11 3.6 ± 1.9
brain – kidney 19 5.39 3.5 ± 0.8
bladder – testis 18 5.12 3.5 ± 0.9
bladder – prostate 17 5.05 3.4 ± 0.9
bladder – pancreas 11 3.28 3.4 ± 1.1
cervix – lung 20 6.14 3.3 ± 0.8BMC Bioinformatics 2005, 6:78 http://www.biomedcentral.com/1471-2105/6/78
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requires the identification of appropriate patient groups
and candidate genes, and both steps can benefit from
effective text-mining of public data sources. OMIM is a
high-quality information source and considered a key ref-
erence database by the genetics community. Our objective
was to establish an automated text-mining system for
OMIM that will identify genetically-related cancers and
cancer-related genes.
Implementation
We developed the computer program CGMIM to text-
mine OMIM. The software considers 21 major cancer
types identified by the National Cancer Institute of Can-
ada [ref [6], page 18, Table 1]. CGMIM recognizes geneti-
cally-related cancers by identifying cancer types
mentioned in association with a specific gene. For pairs of
cancer types, CGMIM generates a table with rows and col-
umns for each cancer type, and cells containing the
number of OMIM gene entries that mention an associa-
tion with those cancers. We refer to this table as the siteX-
site matrix. If several OMIM entries mention one type of
cancer, and several entries mention another type of can-
cer, then some entries will mention both types of cancer
by chance alone. If the mention of different cancers
occurred at random, the expected number of genes (E) in
OMIM that mention two specific types of cancer can be
estimated as the total number of genes related to cancer,
multiplied by the probabilities that an entry mentions
each individual cancer type. The latter probabilities are
estimated as the proportion of genes in OMIM that are
related to each cancer type. Explicitly, if there are N genes
related to cancer, GA genes related to cancer type A and GB
genes related to cancer type B, then
EAB = (GA/N) × (GB/N) × N (1)
where EAB is the expected number of genes related to both
cancer types A and B. The observed number of genes (O)
is the number of OMIM entries that mention both cancer
types, and O/E indicates whether the number of genes
associated with a pair of cancer sites is different than
chance alone would predict. An O/E value of 1.0 indicates
the number of entries observed is the number expected by
chance. An approximate 95% confidence interval (95%
CI) is O/E ± (1.96/√ E).
Our text-mining algorithm begins by separating para-
graphs of an OMIM entry into constituent sentences, and
assumes sentences end with a period followed by a space.
There are many words and phrases that refer to cancer. A
breast cancer might be described as a breast tumor, breast
carcinoma or mammary gland neoplasm. A list of syno-
nyms for each cancer type was developed using the Inter-
national Classification of Disease for Oncology (ICD-O)
[7] and augmented by familiar lay terminology. Other
variation occurs as the result of English grammar. Breast
cancer might be referred to as cancer of the breast, and sev-
eral cancers might be referred to in a list (e.g., "cancer of
the ovary, breast, and skin"). The algorithm identified
OMIM entries for each type of cancer by finding sentences
that included both a site synonym and a cancer synonym.
For phrases in the synonym list, CGMIM searched for sen-
tences containing all of the individual words.
"Stemming" was used to remove capitalization and com-
mon suffixes from words, and thereby changes similar
words to identical word fragments. The process is best
demonstrated with an example.
Unstemmed
Large-cell lymphomas comprise approximately 25% of all
non-Hodgkin lymphomas in children and young adults,
and approximately one-third of these tumors have a
t(2;5)(p23;q35) translocation.
Stemmed
larg-cell lymphoma compris approxim 25% of all non-
hodgkin lymphoma in children and young adult, and
approxim on-third of these tumor have a t(2;5)(p23;q35)
transloc
We used an established algorithm ("Porter's algorithm")
to perform the stemming.[8]
Our list of synonyms was stemmed and then compared to
the stemmed sentences in OMIM. An OMIM entry may
contain alternative entry names, mapping information, a
text summary, references to key publications, examples of
known allelic variants, and a clinical synopsis of the cor-
responding phenotype. Some of these fields are subjec-
tive, such as the examples of allelic variants, and we
restricted our search to the text summary.
Finally, not all OMIM entries refer to specific genes. Some
entries refer to heritable traits for which no gene has been
identified. In addition, more than one OMIM entry can
refer to the same gene. This typically occurs when the
entry for a trait is linked to a gene that was previously
identified and described in a separate OMIM entry.
Because OMIM is dynamically organized and updated,
this type of multiple referencing is unavoidable. To restrict
searches to only the OMIM entries for genes, CGMIM
compares each entry name and alternative names with a
list of gene names assigned by the Human Genome
Organization (HUGO; http://www.gene.ucl.ac.uk/hugo/
).
We performed manual searches of the OMIM database to
identify the strengths and weakness of the computerized
search method, and to iteratively modify the software.BMC Bioinformatics 2005, 6:78 http://www.biomedcentral.com/1471-2105/6/78
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This involved selecting a sample of OMIM entries and
reading through the text to determine whether the entries
referred to a cancer, or if entries were identified by
CGMIM where, in reality, there was no true cancer refer-
ence. We also reviewed the entries to identify sentences
that referred to cancer, but for which evidence indicated
there was no association. (E.g., "An early study showed
the gene was not related to breast cancer.") While an
OMIM entry might include a sentence of that sort, another
sentence in the entry might cite evidence supporting the
association. (E.g., "A subsequent study showed the gene
was related to breast cancer.") Despite the negative state-
ment, this example OMIM entry mentions evidence sup-
porting the association and hence would be included
when tallying entries associated with the cancer.
CGMIM was written in the Perl computer language and
implemented on a Linux workstation. OMIM is updated
daily and we created static copies of the database to pro-
vide a stable reference for search evaluation. The copies of
OMIM used to develop CGMIM were downloaded
between March and October of 2003, and each copy con-
tained more than 14,000 entries.
Results and discussion
In the OMIM database on September 30, 2004, CGMIM
identified 1943 genes related to cancer. BRCA2 (OMIM
*164757), BRAF (OMIM *164757) and CDKN2A (OMIM
*600160) were each related to 14 types of cancer. The
OMIM entries for all three genes mention leukemia,
melanoma, breast cancer, colorectal cancer, pancreatic
cancer, stomach cancer, ovarian cancer and prostate can-
cer. The entry for BRCA2 also mentions cancer of the
brain, larynx, cervix, uterus, thyroid and kidney. The entry
for BRAF also mentions lymphoma and cancer of the
lung, bladder, testes, cervix and uterus. The entry for
CDKN2A also mentions lymphoma and cancer of the
lung, bladder, brain, esophagus and kidney. Each gene
defines a large group of related cancers.
The numbers of genes associated with each pair of cancer
types are summarized in the siteXsite matrix (Figure 1).
Diagonal cells in the matrix contain the total numbers of
genes identified for each cancer type; off-diagonal cells are
the numbers of genes identified by both the row and the
column titles. For example, there were 45 genes related to
cancer of the esophagus, 121 genes related to cancer of the
stomach, and 21 genes related to both. The cancer men-
tioned by the greatest number of OMIM entries was leuke-
mia, and the greatest number of OMIM gene entries that
mention a combination of two cancers was 143 for lym-
phoma and leukemia. For some pairs of cancer sites, no
genes were identified.
The numbers in the off-diagonal cells depend on the
number of genes related to the individual cancers. Based
on the number of OMIM entries that mention leukemia
and lymphoma individually, the number expected to
mention both is 98.3 and the ratio of the observed and
expected values is 1.5 (95% CI 1.3–1.7). (In equation (1),
GLEUKEMIA = 643, GLYMPHOMA = 297 and N = 1943.) This
indicates there are 50% more genes related to both can-
cers than would be expected by chance. Table 1 provides
a list of 20 pairs of cancer types where the ratio of the
observed and expected number of genes in the siteXsite
matrix is greatest. The table indicates that fewer than three
genes in OMIM should mention both cancer of the
esophagus and cancer of the stomach by chance, but 21
entries mention both cancers. This more than seven-fold
discrepancy suggests that cancers of the esophagus and
stomach might be more related than current literature
suggests. Similar conclusions might be made for the other
pairs of cancer types in Table 1.
We randomly selected 25 genes related to cancer and
manually reviewed text of the corresponding OMIM
entries. All of the entries correctly mention one or more
types of cancer, but for 20% of those entries, one of the
cancers was only mentioned in the context of evidence
suggesting no association.
CGMIM can assist in designing effective studies of geneti-
cally-related cancers. CGMIM uses a high-quality database
of genetic information to produce a summary of gene and
cancer associations. A group of cancer types might be
related by physical proximity in the body (e.g., prostate
and bladder cancer), a shared physiologic function (e.g.,
cancers involving the digestive tract), a common exposure
(e.g., cancers caused by air pollution) or a common
genetic characteristic (e.g., cancers in tissues that express
BRCA1). The identification of such groups becomes more
difficult and time-consuming as the literature about genes
and cancer expands, and efficient text-mining tools have
increasing value.
In several ways, groups of cancers that have shared genetic
factors are anticipated to lead to further etiologic hypoth-
eses and advances regarding environmental agents. First,
grouping cancers will be especially useful if a group com-
bines several cancers that are rare and difficult to study
individually. Second, knowledge of genetic pathways
might suggest an environmental factor associated with all
of the cancers. For example, a grouping defined by a
vitamin receptor gene would suggest vitamin intake as a
possible environmental agent in the etiology of all of the
cancers. Third, CGMIM will allow us to design studies that
might extend gene-cancer associations to include cancers
at other sites. The groups can also be used to identify can-
cers that should be considered together in a definition ofBMC Bioinformatics 2005, 6:78 http://www.biomedcentral.com/1471-2105/6/78
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family history, and in selection of genetic tests that might
be adopted for high-risk families. During development of
CGMIM, we observed changes in OMIM and the cancer
groups that it produced from one week to another. This
illustrates the need for a tool that can routinely perform
the analysis, as opposed to a set of results based on the
OMIM contents from a particular day.
OMIM is based on published material from the scientific
literature. The number of genes identified by our program
A siteXsite matrix for 21 major cancer types as reported by the National Cancer Institute of Canada Figure 1
A siteXsite matrix for 21 major cancer types as reported by the National Cancer Institute of Canada. Matrix cells indicate the 
number of genes related to cancers named in the row and column labels. Cell entries are based on cancers mentioned in 
Online Mendelian Inheritance in Man (OMIM; http://www.ncbi.nlm.nih.gov/omim/) searched September 30, 2004.BMC Bioinformatics 2005, 6:78 http://www.biomedcentral.com/1471-2105/6/78
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does not necessarily indicate the relatedness of two or
more cancer types, but rather what is known about those
cancers. This reflects what research has been funded, per-
formed and published. There is more funding for certain
types of cancer, there are more journals that address cer-
tain types of cancer, and there are more people studying
certain types of cancer. Published information reflects our
knowledge base and the scientific literature is hence a
valid basis for identifying cancer groups and genes for fur-
ther study. In some cases, evidence about an association
was based on studies of cell lines or non-human organ-
isms. In other cases, evidence was based on anecdotal
observations in a small number of people. Some associa-
tions were based on several independent studies that each
involved hundreds of patients.
There are sentences in OMIM that contain phrases such as
"is not related to breast cancer". We could not create an
algorithm that recognized all negative references without
overlooking positive valid ones. Some OMIM entries
report both negative and positive evidence of an
association. These "mixed" entries are tallied as positive
reports by CGMIM, consistent with our interest in positive
associations. Other sentences in OMIM describe evidence
of gene expression in both cancerous and normal tissue.
E.g., "... has been shown to be expressed in breast cancer
cells and prostate cells". The sentences are incorrectly
interpreted as mentions of prostate cancer. Manual review
of OMIM indicated that a minority of apparent associa-
tions (about 20%) between a gene and specific type of
cancer were the result of negative evidence and are thus
"false-positive" text-mining associations. We suggest that
a manual review of OMIM associations always precede
subsequent study design and analysis. We assume the
excess 20% is included in every cell of the siteXsite matrix.
Thus expected values also include the 20% excess, and the
O/E ratios are not affected.
Other databases might be used as the basis for assessing
scientific knowledge regarding genetic cancer groupings,
but OMIM offers several advantages. OMIM is based on
all publications in the PubMed database that are related to
a specific human gene or trait. Results based on mining all
of PubMed would be of interest, but would involve a
much larger volume of literature and lack the expert
review that is characteristic of OMIM. More specialized
cancer groupings also might be created using computer-
ized conference proceedings or journal contents. Like-
wise, a list of synonyms might be determined from other
sources such as the UMLS (Unified Medical Language Sys-
tem) Specialist Lexicon of the National Cancer Institute.
We used ICD-O terminology because it is the basis for
most scientific writing on cancer.
This project used resources that have been developed by
the US National Institutes of Health and Human Genome
Project.[3] Our approach is exhaustive of the information
reported in OMIM, will produce a computer algorithm for
near-automatic updating of the review, and has the poten-
tial to be extended to other computerized databases. We
will use CGMIM along with other criteria to guide the
design of studies of genes and environment in cancer
etiology.
Conclusion
CGMIM uses an expert database of genetic information to
determine a summary of gene and cancer associations.
The software identifies genes that are associated with a
particular type of cancer, groups of cancers that share a
common genetic association, and pairs of cancer types
where there are more related genes than expected by
chance.
Availability and requirements
• Project name: CGMIM
• Project home page: http://www.bccrc.ca/ccr/CGMIM
• Operating system: The source code for CGMIM can be
downloaded from the CGMIM homepage and run under
Linux.
• Programming language: The source code for CGMIM
can be downloaded from the CGMIM homepage and is
written in Perl.
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